title: Enhanced apoptosis in metallothionein null cells.
abstract: Metallothioneins (MTs) are major intracellular, zinc-binding proteins with antioxidant properties. Mouse embryonic cells null for MT due to loss of functional MT I and II genes (MT-/-) were more susceptible to apoptotic death after exposure to tert-butyl hydroperoxide or the anti-cancer agents cytosine arabinoside, bleomycin, melphalan, and cis-dichlorodiammineplatinum(II) compared with wild-type mouse embryonic cells (MT+/+). We measured basal levels of the tumor suppressor protein p53 and the death effector protein Bax and found the basal levels of both proteins were higher in MT null cells compared with MT+/+ cells. After treatment with the DNA-damaging agent cis-dichlorodiammineplatinum(II), p53 protein levels were induced in both MT+/+ and MT-/- cells with MT null cells always maintaining the highest p53 levels. The elevated sensitivity to apoptosis was not restricted to embryonic cells. Primary pulmonary fibroblasts were isolated from distinct litters of MT null, heterozygous, and wild-type mice, and all had undetectable basal MT levels. Zinc exposure increased MT levels in the wild-type and heterozygous fibroblasts but not in the MT null fibroblasts. Consistent with the induced MT levels, we found MT+/+ and MT+/- embryonic cells were less sensitive to cis-dichlorodiammineplatinum(II)-induced apoptosis compared with MT-/- cells. Our results implicate MT as a stress-responsive factor that can regulate apoptotic engagement.
authors.affiliation: Department of Pharmacology, University of Pittsburgh, Pennsylvania 15261, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Kondo
authors.forename: J M
authors.initials: JM
authors.lastname: Rusnak
authors.forename: D G
authors.initials: DG
authors.lastname: Hoyt
authors.forename: C E
authors.initials: CE
authors.lastname: Settineri
authors.forename: B R
authors.initials: BR
authors.lastname: Pitt
authors.forename: J S
authors.initials: JS
authors.lastname: Lazo
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001761:Bleomycin / Q000494:pharmacology; D002104:Cadmium / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D002945:Cisplatin / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D053938:DNA Fragmentation; D008558:Melphalan / Q000494:pharmacology; D008668:Metallothionein / Q000172:deficiency*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D009153:Mutagens / Q000494:pharmacology; D016877:Oxidants / Q000494:pharmacology; D010545:Peroxides / Q000494:pharmacology; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism; D015032:Zinc / Q000494:pharmacology; D051028:bcl-2-Associated X Protein; D020122:tert-Butylhydroperoxide
chemical_list: C494827:Bax protein, mouse; D009153:Mutagens; D016877:Oxidants; D010545:Peroxides; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53; D051028:bcl-2-Associated X Protein; D002104:Cadmium; D003561:Cytarabine; D001761:Bleomycin; D008668:Metallothionein; D020122:tert-Butylhydroperoxide; D015032:Zinc; D002945:Cisplatin; D008558:Melphalan